Bajaj Healthcare Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹374.5
- Today's High:
- ₹405.8
- Open Price:
- ₹392.45
- 52W Low:
- ₹245.05
- 52W High:
- ₹457.55
- Prev. Close:
- ₹388.7
- Volume:
- 517447
Company Statistics
- Market Cap.:
- ₹10.26 billion
- Book Value:
- 133.058
- Revenue TTM:
- ₹6.39 billion
- Operating Margin TTM:
- 11.84%
- Gross Profit TTM:
- ₹1.84 billion
- Profit Margin:
- -2.69%
- Return on Assets TTM:
- 6.25%
- Return on Equity TTM:
- 12.36%
Company Profile
Bajaj Healthcare Limited had its IPO on under the ticker symbol BAJAJHCARE.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Bajaj Healthcare Limited has a staff strength of 0 employees.
Stock update
Shares of Bajaj Healthcare Limited opened at ₹392.45 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹374.5 - ₹405.8, and closed at ₹382.25.
This is a -1.66% slip from the previous day's closing price.
A total volume of 517,447 shares were traded at the close of the day’s session.
In the last one week, shares of Bajaj Healthcare Limited have increased by +2.15%.
Bajaj Healthcare Limited's Key Ratios
Bajaj Healthcare Limited has a market cap of ₹10.26 billion, indicating a price to book ratio of 3.2736 and a price to sales ratio of 1.6326.
In the last 12-months Bajaj Healthcare Limited’s revenue was ₹6.39 billion with a gross profit of ₹1.84 billion and an EBITDA of ₹1.05 billion. The EBITDA ratio measures Bajaj Healthcare Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Bajaj Healthcare Limited’s operating margin was 11.84% while its return on assets stood at 6.25% with a return of equity of 12.36%.
In Q2, Bajaj Healthcare Limited’s quarterly earnings growth was a negative -79.5% while revenue growth was a negative 24.6%.
Bajaj Healthcare Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 28.7587
- PEG
Its diluted EPS in the last 12-months stands at ₹12.93 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bajaj Healthcare Limited’s profitability.
Bajaj Healthcare Limited stock is trading at a EV to sales ratio of 2.0749 and a EV to EBITDA ratio of 12.7117. Its price to sales ratio in the trailing 12-months stood at 1.6326.
Bajaj Healthcare Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 11.59%.
Balance sheet and cash flow metrics
- Total Assets
- ₹9.01 billion
- Total Liabilities
- ₹4.36 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 11.59%
Bajaj Healthcare Limited ended 2024 with ₹9.01 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹9.01 billion while shareholder equity stood at ₹3.68 billion.
Bajaj Healthcare Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹4.36 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹177.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹936.62 million.
Bajaj Healthcare Limited’s total current assets stands at ₹5.10 billion while long-term investments were ₹0 and short-term investments were ₹46.00 million. Its net receivables were ₹2.27 billion compared to accounts payable of ₹847.53 million and inventory worth ₹2.09 billion.
In 2024, Bajaj Healthcare Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Bajaj Healthcare Limited paid ₹0.12 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹382.25
- 52-Week High
- ₹457.55
- 52-Week Low
- ₹245.05
- Analyst Target Price
- ₹
Bajaj Healthcare Limited stock is currently trading at ₹382.25 per share. It touched a 52-week high of ₹457.55 and a 52-week low of ₹457.55. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹341.11 and 200-day moving average was ₹350.98 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7363.2% of the company’s stock are held by insiders while 172.2% are held by institutions.
Frequently Asked Questions About Bajaj Healthcare Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Bajaj HealthCare Limited, a pharmaceutical company, research, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company’s product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides formulations in the form of tablets, capsules, and oral powder, as well as intermediates and impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.